By Topic

Optimization of the [18F]FDG protocol for clinical cerebral studies in 3D PET

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)

The aim of this work was to optimize the [18F]FDG cerebral protocol for 3D PET acquisitions on the EXACT HR+. We compared the noise equivalent counts (NEC) and the quantitation of 2D and 3D acquisitions both performed in 7 patients. The 2D and 3D scans were acquired sequentially during respectively 20 and 5 minutes after an injection of 160 to 255 MBq of [18F]FDG. A plasma input function was measured in three patients. The NEC analysis indicated that the optimal dose of [18F]FDG was close to 200 MBq for a 3D brain acquisition. Using this dose, a 3.5-fold increase in NEC was obtained in 3D compared to 2D allowing thus the acquisition time to be reduced to 6 minutes without any loss of NEC. First results in three subjects indicated slightly higher regional cerebral metabolism rate of the glucose (rCMRglc) in 3D than in 2D: the slope of the linear regression onto the 3D versus 2D rCMRglc values equaled 1.07±0.008, 1.04±0.006 and 1.07±0.005 (p<0.0001). The discrepancy between 2D and 3D values may be due in part to an overestimation of the scatter in 2D and to an undercorrection for the scatter component originating from out of FOV sources in 3D

Published in:

Nuclear Science Symposium, 1996. Conference Record., 1996 IEEE  (Volume:3 )

Date of Conference:

2-9 Nov 1996